TrialBritish journal of clinical pharmacology2025

Pharmacology and safety of TAS5315, a Bruton tyrosine kinase inhibitor, in healthy volunteers: First-in-human, randomized, ascending-dose studies.

Yuji Kumagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.